Ledger.Open graph →
SEC Form D · filed September 23, 2022

Axcella Health Inc

Offering
$12.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Paul D. Sekhri · Cambridge, MADirectorCristina M. Rondinone · Cambridge, MADirectorDavid R. Epstein · Cambridge, MADirectorMichael D. Rosenblatt · Cambridge, MADirectorWilliam Hinshaw · Cambridge, MAExec · DirectorMartin D. Hendrix · Cambridge, MADirectorMargaret Koziel · Cambridge, MAExecVirginia Dean · Cambridge, MAExecGary D. Pisano · Cambridge, MADirectorRobert Crane · Bedford, MAExecCatherine A. Sohn · Cambridge, MADirectorWilliam D. Baird · CAMBRIDGE, MADirectorPaul Fehlner · Cambridge, MAExecWilliam Hinshaw · Cambridge, MAExec · DirectorPaul D. Sekhri · Cambridge, MADirectorMartin D. Hendrix · Cambridge, MADirectorCristina M. Rondinone · Cambridge, MADirectorMargaret Koziel · Cambridge, MAExecVirginia Dean · Cambridge, MAExecGary D. Pisano · Cambridge, MADirectorDavid R. Epstein · Cambridge, MADirectorRobert Crane · Cambridge, MAExecCatherine A. Sohn · Cambridge, MADirectorWilliam D. Baird · CAMBRIDGE, MADirectorPaul Fehlner · Cambridge, MAExecMichael D. Rosenblatt · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗